From: Effects of intermittent hemodialysis on plasmatic levels of endocan
Sex, male | 6 (55%) |
Age, years | 66 (59–69) |
Body weight on ICU admission, kg | 80 (72–96) |
SAPS II on ICU admission | 48 (41–72) |
Disorder category | |
Medical | 8 (73%) |
Surgical | 3 (27%) |
Preexisting conditions | |
Chronic kidney failure | 5 (45%) |
Chronic heart failure | 3 (27%) |
Cirrhosis | 1 (9%) |
Diabetes mellitus | 4 (36%) |
Diagnosis on ICU admission | |
Soft tissues infection | 3 (27%) |
Pneumonia | 3 (27) |
Carbon monoxide poisoning | 1 (9%) |
Decompensated cirrhosis | 1 (9%) |
Cardiogenic shock | 1 (9%) |
Hemorrhagic shock | 1 (9%) |
Gas embolism | 1 (9%) |
Inflammation biomarkers on day of hemodialysis | |
CRP, mg/l | 66 (41–154) |
Procalcitonin, ng/ml | 2 (1.4–2.8) |
Characteristics of hemodialysis | |
Residual volume of diuresis (ml/24 h) | 100 (25–450) |
Systemic anticoagulation | 8 (72%) |
Daily UFH dose, IU/24 h | 10000 (0; 12000) |
Heparin-coated membrane (EVODIAL) | 3 (27%) |
Duration of hemodialysis, hrs | 5 (4.5–6) |
Blood flow rate, ml/min | 250 (250–250) |
Dialysate flow rate, ml/min | 500 (500–500) |
Ultrafiltration volume, ml | 2000 (860–2500) |
Ultrafiltration rate, ml/h | 333 (240–500) |